Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-α in patients with chronic hepatitis C

Annals of Internal Medicine

Volumn 126, Issue 11, 1997, Pages 874-881

  Martinot, Michèle ^c   Marcellin, Patrick ^c   Boyer, Nathalie ^c   Detmer, Jill ^a   Pouteau, Michèle ^c   Castelnau, Corinne ^c   Degott, Claude ^b   Aupérin, Anne ^c   Collins, Mark ^a   Kolberg, Janice ^a   Wilber, Judith ^a   Benhamou, Jean Pierre ^c   Erlinger, Serge ^c  

^a NOVARTIS PHARMA AG   (Switzerland)

^b BEAUJON HOSPITAL   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; VIRUS RNA;

ADULT; ARTICLE; DISEASE SEVERITY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOTHERAPY; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030923160     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-126-11-199706010-00004     Document Type: Article

References (26)

1. Simons JN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG, et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci U S A. 1995;92:3401-5.
2. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med. 1995;1:564-9.
3. Linnen J, Wages J Jr, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 1996;271:505-8.
4. Schmidt B, Korn K, Fleckenstein B. Molecular evidence for transmission of hepatitis G virus by blood transfusion [Letter]. Lancet. 1996;347:909.
5. Aikawa T, Sugai Y, Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C [Letter]. N Engl J Med. 1996;334:195-6.
6. Masuko K, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, et al. Infection with hepatitis GB virus in patients on maintenance hemodialysis. N Engl J Med. 1996;334:1485-90.
7. de Lamballerie X, Charrel RN, Dussol B. Hepatitis GB virus in patients on hemodialysis [Letter]. N Engl J Med. 1996;334:1549.
8. Nübling CM, Lôwer J. GB-C genomes in a high-risk group, in plasma pools, and in intravenous immunoglobulin [Letter]. Lancet. 1996;347:68.
9. Feucht HH, Zöllner B, Polywka S, Laufs R. Vertical transmission of hepatitis G [Letter]. Lancet. 1996;347:615.
10. Yoshiba M, Okamoto H, Mishiro S. Detection of GBV-C hepatitis C virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet. 1995;346:1131-2.
11. Kuroki T, Nishiguchi S, Tanaka M, Enomoto M, Kobayashi K. Does GBV-C cause fulminant hepatitis in Japan? [Letter]. Lancet. 1996;347:908.
12. Sallie R, Shaw J, Mutimer D. GBV-C virus and fulminant hepatic failure. Lancet. 1996;347:1552.
13. Alter HJ. The cloning and clinical implications of HGV and HGBV-C [Editorial]. N Engl J Med. 1996;334:1536-7.
14. Tanaka E, Alter HJ, Nakatsuji Y, Shih WK, Kim J, Matsumoto A, et al. Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med. 1996;125:740-3.
15. Marcellin P, Pouteau M, Boyer N, Degos F, Castelnau C, Degott C, et al. Usefulness of prolonging interferon therapy according to the initial response in patients with chronic hepatitis C without cirrhosis [Abstract]. Hepatology. 1994;20:154.
16. Benhamou JP, Hopft U, Rizetto M, Sanchez-Tapias JM, Braconnier JH, Bulher H, et al. Long-term lymphoblastoid interferon enhances sustained response and improves histological activity up to 12 months post-treatment [Abstract]. Hepatology. 1995;22:37.
17. Bacon BR, Farell G, Benhamou JP, Hopft U, Barcena R, Feinman V, et al. Lymphoblastoid interferon improves long-term response to a six month course of treatment when compared with recombinant interferon alfa 2b: results of an international trial [Abstract]. Hepatology. 1995;22:37.
18. Knodell RG, Ishak KG, Black WC, Chen TS, Craig TR, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1:431-5.
19. Horn T, Chang CA, Collins ML. Hybridization properties of the 5-methyl-isocytidine/isoguanosine base pair in synthetic oligodeoxynucleotides. Tetrahedron Letters. 1995;36:2033-6.
20. Detmer J, Lagier R, Flynn J, Zayati C, Kolberg J, Collins M, et al. Accurate quantification of hepatitis C virus (HCV) RNA from all genotypes by using branched-DNA technology. J Clin Microbiol. 1996;34:901-7.
21. Collins ML, Zayati C, Detmer JJ, Daly B, Kolberg JA, Cha TA, et al. Preparation and characterization of RNA standards for use in quantitative branched DNA hybridization assays. Analytical Biochem. 1995;226:120-9.
22. Young KK, Resnick RM, Myers TW. Detection of hepatitis C virus RNA by combined reverse transcription-polymerase chain reaction assay. J Clin Microbiol. 1993;31:882-6.
23. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol. 1993;74:1093-102.
24. Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, et al. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology. 1995;22(4 Pt 1):1050-6.
25. Ohto H, Terazawa S, Sasaki N, Sasaki N, Hino K, Ishiwata C, et al. Transmission of hepatitis C from mothers to infants. The Vertical Transmission of Hepatitis C Virus Study Group. N Engl J Med. 1994;330:744-50.
26. Tong MJ, el-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med. 1995;332:1463-6.